ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för nabumetone. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

19 träffar

Bibliografisk träff 2013-10-22

Characterization of polymer adsorption onto drug nanoparticles using depletion measurements and small-angle neutron scattering.

Goodwin DJ, Sepassi S, King SM, Holland SJ, Martini LG, Lawrence MJ.

Mol Pharm · research support, non-u.s. gov't; journal article · DOI 10.1021/mp400138e

Bibliografisk träff 2013-09-12

Identification of combined conjugation of nabumetone phase I metabolites with glucuronic acid and glycine in minipig biotransformation using coupling high-performance liquid chromatography with electrospray ionization mass spectrometry.

Česlová L, Holčapek M, Nobilis M.

J Pharm Biomed Anal · journal article · DOI 10.1016/j.jpba.2013.08.053

Bibliografisk träff 2013-07-01

Hypersensitivity to nabumetone: cross reactivity with naproxen.

Perez-Ezquerra PR, Sanchez-Morillas L, Laguna Martinez JJ, Gonzalez Mendiola R, Gomez-Traseira C, Carrasco Garcia I, Herranz Mañas M, Rubio Matos A.

Ann Allergy Asthma Immunol · letter; case reports · DOI 10.1016/j.anai.2013.05.006

Bibliografisk träff 2013-04-01

Effects of nabumetone and dipyrone on experimentally induced gastric ulcers in rats.

Yıldırım E, Sağıroğlu O, Kılıç FS, Erol K.

Inflammation · comparative study; journal article · DOI 10.1007/s10753-012-9568-9

Bibliografisk träff 2013-03-19

Analytical power of LLE-HPLC-PDA-MS/MS in drug metabolism studies: identification of new nabumetone metabolites.

Nobilis M, Mikušek J, Szotáková B, Jirásko R, Holčapek M, Chamseddin C, Jira T, Kučera R, Kuneš J, Pour M.

J Pharm Biomed Anal · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jpba.2013.03.006

Bibliografisk träff 2013-01-24

A diclofenac suppository-nabumetone combination therapy for arthritic pain relief and a monitoring method for the diclofenac binding capacity of HSA site II in rheumatoid arthritis.

Setoguchi N, Takamura N, Fujita K, Ogata K, Tokunaga J, Nishio T, Chosa E, Arimori K, Kawai K, Yamamoto R.

Biopharm Drug Dispos · controlled clinical trial; journal article · DOI 10.1002/bdd.1829

Bibliografisk träff 2012-11-06

Progression of macular atrophy after PDT combined with the COX-2 inhibitor Nabumetone in the treatment of neovascular ARMD.

Sin M, Chrapek O, Karhanova M, Pracharova Z, Langova K, Rehak J.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.5507/bp.2012.066

Bibliografisk träff 2012-09-28

Role of carbonyl reducing enzymes in the phase I biotransformation of the non-steroidal anti-inflammatory drug nabumetone in vitro.

Skarydova L, Nobilis M, Wsól V.

Xenobiotica · research support, non-u.s. gov't; journal article · DOI 10.3109/00498254.2012.720048

Bibliografisk träff 2012-09-13

Simultaneous determination of nabumetone and its principal metabolite in medicines and human urine by time-resolved fluorescence.

Murillo Pulgarín JA, Alañón Molina A, Martínez Ferreras F.

Analyst · research support, non-u.s. gov't; journal article · DOI 10.1039/c2an35412h

Bibliografisk träff 2012-03-27

Flash pulmonary oedema: a rare but serious side effect of quinine sulphate.

Raine D, Lee A, Wiedmann R.

BMJ Case Rep · journal article; case reports; case-report · DOI 10.1136/bcr.03.2011.4040

Bibliografisk träff 2012-03-01

Toxicology of frequently encountered nonsteroidal anti-inflammatory drugs in dogs and cats.

Khan SA, McLean MK.

Vet Clin North Am Small Anim Pract · review; journal article · DOI 10.1016/j.cvsm.2012.01.003

Bibliografisk träff 2012-02-01

Development and validation of a stability-indicating RP-UPLC method for the quantitative analysis of nabumetone in tablet dosage form.

Sethi N, Anand A, Chandrul KK, Jain G, Srinivas KS.

J Chromatogr Sci · validation study; journal article · DOI 10.1093/chromsci/bmr001

Bibliografisk träff 2012-01-01

UV-visible spectrophotometric simultaneous estimation of paracetamol and nabumetone by AUC method in combined tablet dosage form.

Rote AR, Kumbhoje PA, Bhambar RS.

Pharm Methods · research-article; journal article · DOI 10.4103/2229-4708.97722

Bibliografisk träff 2011-10-20

Drug discovery for Duchenne muscular dystrophy via utrophin promoter activation screening.

Moorwood C, Lozynska O, Suri N, Napper AD, Diamond SL, Khurana TS.

PLoS One · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1371/journal.pone.0026169

Bibliografisk träff 2011-10-01

Discovery of nonsteroidal anti-inflammatory drug and anticancer drug enhancing reprogramming and induced pluripotent stem cell generation.

Yang CS, Lopez CG, Rana TM.

Stem Cells · research-article; journal article · DOI 10.1002/stem.717

Bibliografisk träff 2011-10-01

First-order derivative spectrophotometric estimation of nabumetone and paracetamol in tablet dosage form.

Rote AR, Bhalerao SR.

Pharm Methods · research-article; journal article · DOI 10.4103/2229-4708.93397

Bibliografisk träff 2011-06-15

Drug release from hydrazone-containing peptide amphiphiles.

Matson JB, Stupp SI.

Chem Commun (Camb) · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1039/c1cc12570b

Bibliografisk träff 2011-02-01

[Determination of nabumetone and 6-methoxy-2-naphthylacetic acid in plasma using HPLC with UV and MS detection].

Nespesná L, Stícha M, Matousková O, Perlík F, Slanar O.

Ceska Slov Farm · journal article

Bibliografisk träff 2011-01-01

In vitro characterization of the cytochrome P450 isoforms involved in the metabolism of 6-methoxy-2-napthylacetic acid, an active metabolite of the prodrug nabumetone.

Matsumoto K, Nemoto E, Hasegawa T, Akimoto M, Sugibayashi K.

Biol Pharm Bull · journal article · DOI 10.1248/bpb.34.734